PlexusDx supports a flexible, patient-centered escalation model because your long-term success depends on sustainable tolerance, not arbitrary timelines
GLP-1 therapy offers a potential pathway to address those residual symptoms
zebit0 April 15, 2026, 4:45am #8 Assuming someone does not have Wilsons disease or is even a carrier for it, in which case the remarkably high dose would be significantly lower (for carriers) or lethal (for those with Wilsons)
Blood sugar fluctuations , which can cause fatigue, dizziness, or headaches
But here's where things get really exciting: these unexpected brain perks could shake up how we approach all sorts of neurological and psychiatric conditions
The community-documented norm is to pick a bac water volume that makes the per-dose unit count land on a clean number 10 units, 20 units, 25 units so dose errors at the syringe step are minimized